715
Views
30
CrossRef citations to date
0
Altmetric
Reviews

System-based drug discovery within the human kinome

Pages 1053-1070 | Published online: 13 Sep 2012
 

Abstract

Introduction: For well over a decade, significant effort has been devoted to the search for inhibitors of the human protein kinase family. This is increasingly translating into success in the clinic, with five new kinase inhibitor drugs approved since 2011. However, despite encouraging signs in other areas, success has been largely restricted to oncology.

Areas covered: This article reviews the prospects for kinase inhibitor drug discovery in oncology and other therapeutic areas. Major topics include the application of kinome profiling and lessons learned from kinase system-based research. With these fields nearing maturity, the validation of kinases as targets or their classification as liabilities is becoming increasingly pertinent. Other topics include a discussion of the properties required of good small molecule kinase probes.

Expert opinion: The tractability of protein kinases to small molecule discovery through system-based research is excellent, and adequate selectivity can often be achieved. With advances in screening methodology now enabling compound profiling across most of the kinome, researchers involved in drug discovery must decide what inhibition profiles are desirable. However, this assessment must be made on the basis of incomplete understanding of the disease biology of most kinases, and as a result there is a significant risk that drugs entering clinical trials will lack efficacy. Because of this, as well as greater effort to determine which kinases are therapeutically relevant for particular diseases, opportunities for quality pre-candidate compounds developed for specific indications to find alternative uses should be maximised by early screening through panels of phenotypic assays.

Acknowledgements

Thanks to S Davidas for thoughtful comments on trends in published patents, and J Christopher, C-W Chung and D Miller for careful reading of the draft manuscript.

Notes

This box summarises key points contained in the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.